Literature DB >> 9712429

Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.

T M Wheeler1, O Dillioglugil, M W Kattan, A Arakawa, S Soh, K Suyama, M Ohori, P T Scardino.   

Abstract

This study was performed to assess the relationship between the level and extent of prostatic capsular invasion (PCI) by cancer and the clinical and pathological features and prognosis of early-stage prostate cancer. We conducted a retrospective analysis of the clinical (age, stage, grade, prostate specific antigen [PSA] level) and pathological (tumor volume, stage, grade, surgical margins) features of 688 patients treated with radical prostatectomy to determine the pathological features and probability of recurrence associated with various levels of PCI. Radical prostatectomy specimens were serially sectioned and examined by whole-mount technique. Progression-free probabilities (PFP) after radical prostatectomy were determined by Kaplan-Meier and Cox proportional hazards regression analysis. Progression was defined as a rising serum PSA < or = 0.4 ng/mL or clinical evidence of recurrent cancer. Increasing clinical stage, Gleason grade in the biopsy specimen, and pretreatment serum PSA levels were each associated with increasing levels of PCI (P < .001). In the radical prostatectomy specimen, increasing levels of PCI were significantly associated with increasing tumor volume (P < .001), Gleason grade (P < .0001), seminal vesicle involvement (SVI, P < .001) and lymph node metastases (+LN, P < .001). None of 138 patients without capsular invasion had SVI or lymph node metastases (+LN), and all remained free of progression, even though some had large volume (up to 6.26 cm3) or poorly differentiated (Gleason sum up to 8) cancers. Invasion into the capsule (n = 271) was occasionally associated with SVI (6%) or +LN (3%) and a significantly (log-rank test) lower PFP of 87% at 5 years. Focal and extensive extraprostatic extension (EPE) were associated with progressively increased risk of SVI and +LN and lower PFP (73% and 42%, respectively). In a multivariate analysis, the level of PCI was an independent prognostic factor (P < .001). There is a strong association between the level of invasion of cancer into or through the prostatic capsule and the volume, grade, pathological stage, and rate of recurrence after radical prostatectomy. Prostate cancer does not appear to metastasize in the absence of invasion into the capsule regardless of the volume or grade of the intracapsular tumor. Subclassification of patients according to the levels of PCI provides valuable prognostic information.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712429     DOI: 10.1016/s0046-8177(98)90457-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  35 in total

1.  Accuracy of preoperative endo-rectal coil magnetic resonance imaging in detecting clinical under-staging of localized prostate cancer.

Authors:  Antonio B Porcaro; Alessandro Borsato; Mario Romano; Teodoro Sava; Claudio Ghimenton; Filippo Migliorini; Carmelo Monaco; Emanuele Rubilotta; Stefano Zecchini Antoniolli; Vincenzo Lacola; Stefania Montemezzi
Journal:  World J Urol       Date:  2012-07-07       Impact factor: 4.226

2.  Factors determining biochemical recurrence in low-risk prostate cancer patients who underwent radical prostatectomy.

Authors:  Sıtkı Ün; Hakan Türk; Osman Koca; Rauf Taner Divrik; Ferruh Zorlu
Journal:  Turk J Urol       Date:  2015-06

3.  [Decreased number of R1-resections in radical retropubic prostatectomy. Use of a newly developed fast sectioning technique].

Authors:  P M Braun; K Meyer-Schell; C Seif; S Hautmann; I Leuschner; G Klöppel; K-P Jünemann
Journal:  Urologe A       Date:  2005-11       Impact factor: 0.639

Review 4.  [Diagnostics of radical prostatectomy specimens. Results of the 2009 consensus conference of the International Society of Urological Pathology].

Authors:  G Kristiansen; J R Srigley; B Delahunt; L Egevad
Journal:  Pathologe       Date:  2012-07       Impact factor: 1.011

5.  Impact of the extent of extraprostatic extension defined by Epstein's method in patients with negative surgical margins and negative lymph node invasion.

Authors:  T Maubon; N Branger; C Bastide; G Lonjon; K-A Harvey-Bryan; P Validire; S Giusiano; D Rossi; X Cathelineau; F Rozet
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-07-12       Impact factor: 5.554

Review 6.  Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.

Authors:  Matthew J Watson; Arvin K George; Mahir Maruf; Thomas P Frye; Akhil Muthigi; Michael Kongnyuy; Subin G Valayil; Peter A Pinto
Journal:  Future Oncol       Date:  2016-07-12       Impact factor: 3.404

7.  A Grading System for Extraprostatic Extension of Prostate Cancer That We Can All Agree Upon?

Authors:  Peter L Choyke
Journal:  Radiol Imaging Cancer       Date:  2020-01-17

8.  Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples.

Authors:  Metka Volavšek; Vanessa Henriques; Ana Blanca; Rodolfo Montironi; Liang Cheng; Maria R Raspollini; Alessia Cimadamore; Nuno Vau; Francesco Pierconti; Antonio Lopez-Beltran
Journal:  Virchows Arch       Date:  2019-10-07       Impact factor: 4.064

9.  Impact of a preoperatively estimated prostate volume using transrectal ultrasonography on surgical and oncological outcomes in a single surgeon's experience with robot-assisted radical prostatectomy.

Authors:  Yosuke Hirasawa; Yoshio Ohno; Jun Nakashima; Kenji Shimodaira; Takeshi Hashimoto; Tatsuo Gondo; Makoto Ohori; Masaaki Tachibana; Kunihiko Yoshioka
Journal:  Surg Endosc       Date:  2015-11-17       Impact factor: 4.584

Review 10.  Pathologic basis of focal therapy for early-stage prostate cancer.

Authors:  Vladimir Mouraviev; Janice M Mayes; Thomas J Polascik
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.